UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040133
Receipt number R000045762
Scientific Title ERAS in pancreaticoduodenectomy: A meta-analysis of RCT
Date of disclosure of the study information 2020/04/12
Last modified on 2020/04/12 11:18:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of an enhanced recovery after surgery protocol in pancreaticoduodenectomy: A meta-analysis of randomized controlled trials

Acronym

ERAS in pancreaticoduodenectomy: A meta-analysis of RCT

Scientific Title

ERAS in pancreaticoduodenectomy: A meta-analysis of RCT

Scientific Title:Acronym

ERAS in pancreaticoduodenectomy: A meta-analysis of RCT

Region

Japan Europe


Condition

Condition

Patients undergoing pancreaticoduodenectomy

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to clarify the significance of enhanced recovery after surgery on short-term outcomes in pancreaticoduodenectomy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is short-term outcomes in pancreaticoduodenectomy

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Inclusion criteria were as follows:
patients undergoing pancreaticoduodenectomy; the assessment of ERAS; and postoperative ou
tcomes.

Key exclusion criteria

Records without abstracts, confer
ence abstracts, case reports, retrospective studies and reviews were excluded.

Target sample size

700


Research contact person

Name of lead principal investigator

1st name Kosei
Middle name
Last name Takagi

Organization

Erasmus MC

Division name

Surgery

Zip code

3015 GD

Address

Dr. Molewaterplein 40,

TEL

+31643802627

Email

k.takagi@erasmusmc.nl


Public contact

Name of contact person

1st name Kosei
Middle name
Last name Takagi

Organization

Erasmus MC

Division name

Surgery

Zip code

3015 GD

Address

Dr. Molewaterplein 40,

TEL

+31643802627

Homepage URL


Email

k.takagi@erasmusmc.nl


Sponsor or person

Institute

Erasmus MC

Institute

Department

Personal name



Funding Source

Organization

Erasmus MC

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

N/A

Address

N/A

Tel

+31643802627

Email

k.takagi@erasmusmc.nl


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 04 Month 12 Day

Date of IRB


Anticipated trial start date

2020 Year 04 Month 12 Day

Last follow-up date

2020 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Ethical approval: No ethical appro
val or informed consent statemen
t was required for this review arti
cle.


Management information

Registered date

2020 Year 04 Month 12 Day

Last modified on

2020 Year 04 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045762


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name